When there will never be a randomized controlled trial

Julia J. Scialla; Myles Wolf

doi:10.1038/ki.2015.123

When there will never be a randomized controlled trial

Julia J. Scialla, Myles Wolf^*

^*Corresponding author for this work

Medicine, Nephrology Division

Research output: Contribution to journal › Comment/debate › peer-review

10 Scopus citations

Abstract

There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.

Original language	English (US)
Pages (from-to)	220-222
Number of pages	3
Journal	Kidney international
Volume	88
Issue number	2
DOIs	https://doi.org/10.1038/ki.2015.123
State	Published - Aug 4 2015

Funding

Julia J. Scialla is supported by National Institutes of Health grant K23-DK095949. Myles Wolf is supported by National Institutes of Health grants R01-DK076116, R01-DK081374, R01-DK094796, K24-DK093723, and U01-DK099930.

ASJC Scopus subject areas

Nephrology

Access to Document

10.1038/ki.2015.123

Cite this

@article{dbf1e4cebf3c44c4bc39551937edefc2,

title = "When there will never be a randomized controlled trial",

abstract = "There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.",

author = "Scialla, {Julia J.} and Myles Wolf",

note = "Publisher Copyright: {\textcopyright} 2015 International Society of Nephrology.",

year = "2015",

month = aug,

day = "4",

doi = "10.1038/ki.2015.123",

language = "English (US)",

volume = "88",

pages = "220--222",

journal = "Kidney international",

issn = "0085-2538",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - When there will never be a randomized controlled trial

AU - Scialla, Julia J.

AU - Wolf, Myles

PY - 2015/8/4

Y1 - 2015/8/4

N2 - There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.

AB - There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=84938527226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938527226&partnerID=8YFLogxK

U2 - 10.1038/ki.2015.123

DO - 10.1038/ki.2015.123

M3 - Comment/debate

C2 - 26230199

AN - SCOPUS:84938527226

SN - 0085-2538

VL - 88

SP - 220

EP - 222

JO - Kidney international

JF - Kidney international

IS - 2

ER -

When there will never be a randomized controlled trial

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this